Nuveen Asset Management, LLC Taro Pharmaceutical Industries LTD Transaction History

Nuveen Asset Management, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$40.97 - $43.33 $463,780 - $490,495	11,320 Added 32.77%	45,865 $1.94 Million
Q4 2023 Feb 14, 2024	BUY	$32.77 - $42.31 $424,109 - $547,576	12,942 Added 59.91%	34,545 $1.44 Million
Q2 2023 Aug 14, 2023	BUY	$24.24 - $40.97 $523,656 - $885,074	21,603 New	21,603 $819,000
Q4 2022 Feb 14, 2023	BUY	$27.6 - $32.99 $146,059 - $174,583	5,292 Added 9.65%	60,137 $1.75 Million
Q3 2022 Nov 14, 2022	BUY	$28.74 - $39.9 $30,608 - $42,493	1,065 Added 1.98%	54,845 $1.65 Million
Q2 2022 Aug 15, 2022	BUY	$35.0 - $43.59 $11,165 - $13,905	319 Added 0.6%	53,780 $1.95 Million
Q4 2021 Feb 14, 2022	SELL	$47.6 - $65.0 $438,776 - $599,170	-9,218 Reduced 14.71%	53,461 $2.61 Million
Q3 2021 Nov 12, 2021	BUY	$62.34 - $73.38 $323,856 - $381,209	5,195 Added 9.04%	62,679 $4.06 Million
Q2 2021 Aug 16, 2021	BUY	$70.26 - $76.64 $212,466 - $231,759	3,024 Added 5.55%	57,484 $4.14 Million
Q1 2021 May 17, 2021	BUY	$70.48 - $79.95 $2.82 Million - $3.2 Million	40,036 Added 277.57%	54,460 $4.02 Million
Q4 2020 Feb 16, 2021	BUY	$54.4 - $73.42 $784,665 - $1.06 Million	14,424 New	14,424 $1.06 Million

17K

Ticker TARO
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 37,584,600
Description
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.